CEO, Clarient, GE Healthcare
Cynthia (Cindy) Collins, CEO Clarient, GE Healthcare, has over 30 years of experience in leading global teams in diagnostics, biotech, and pharmaceutical businesses and most recently served as President and CEO of GenVec, Inc., a publicly-traded biopharmaceutical company focused on developing gene therapies and vaccines. Ms. Collins previously served as Group Vice President, Cellular Analysis Business of Beckman Coulter until its sale to Danaher in 2011. Prior to joining Beckman Coulter, Ms. Collins served as President and CEO of Sequoia Pharmaceuticals, Inc., a private biotechnology company developing antiviral drugs for HIV and HCV. Before joining Sequoia Pharmaceuticals, Ms. Collins served as President of Clinical Micro Sensors, Inc., a wholly owned subsidiary of Motorola (now GenMark Diagnostics) where she directed the development and commercialization of molecular diagnostic microarray products and led the eventual strategic divestiture of the division. Before Motorola, she spent over 17 years at Baxter Healthcare in a variety of executive roles, including President of Global Oncology and Vice President of Strategy and Portfolio Management of the BioScience business. Prior to joining Baxter Healthcare, she worked six years in the Diagnostics Division of Abbott Laboratories in a series of operational assignments. Ms. Collins received her BS degree in Microbiology from the University of Illinois, Urbana and her MBA, with a specialization in marketing, from the The University of Chicago Booth School of Business.